The impact of enhanced recovery after surgery (ERAS) on opioid consumption after cesarean delivery

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20221029003

Enrollment

120

Registered

2022-10-29

Start date

2021-03-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patient undergo cesarean delivery enhanced recovery after surgery ERAS cesarean delivery opioid consumption

Interventions

Patients undergo cesarean delivery under conventional protocol,Patients undergo cesarean delivery under ERAS protocol

Treatment,Treatment

Conventional group,ERAS group

Eligibility

Sex/Gender

Female

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant patients undergo cesarean delivery, 2. ASA physical status 1-3, 3. History of opioid dependence, 4. History of chronic pain 5. History of allergy to opioids, ketorolac, paracetamol, ibuprofen, 6. History of asthma

Exclusion criteria

Exclusion criteria: 1. Body Mass Index more than 35.0 kg/m2, 2. Obstetric life-threatening conditions,

Design outcomes

Primary

Measure	Time frame
Opioid consumption 24 hours post-operatively and total consumption milligram-morphine equivalents	—

Secondary

Measure	Time frame
post-operative pain score at 1, 24 and 48 hours Patient reported outcome using a verbal numerical rating score,Hospital length of stay after operation until discharge from hospital review medical record,Maternal and neonatal complications after operation until discharge from hospital review medical record	—

Countries

Thailand

Contacts

Public ContactLapuskorn Yapanan

School of Medicine, University of Phayao

pp.lapuskorn@gmail.com054466666

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026